Korean Government Scholarship Program

EQS-News: EcoGraf Limited: SungEel Hitech Recycled Anode Material Performance

Retrieved on: 
Wednesday, March 22, 2023
Graphite, Partnership, LCA, Korean Government Scholarship Program, ASX, FSE, FMK, Carbon, Government, Plant, KOSDAQ, EGR, OTCQX, Ampere-hour, German Research Institute for Public Administration, SK Innovation, Electric battery

The anode recycled material performance was evaluated in a 2032-coin cell with the reversible capacity reporting 361.1 mAh/g achieved at the 3rd cycle.

Key Points: 
  • The anode recycled material performance was evaluated in a 2032-coin cell with the reversible capacity reporting 361.1 mAh/g achieved at the 3rd cycle.
  • SungEel is one of the largest lithium-ion battery recycling groups in Asia and listed on the KOSDAQ exchange in July 2022.
  • EcoGraf is supporting SungEel to include a tailored EcoGraf HFfree anode recycling process in their proposed new South Korean and European recycling plants to support SungEel ecofriendly process and provide a total recycling solution for lithium-ion batteries.
  • The opportunity also exists to support the uptake of anode recycled material in the lithium-ion battery through blending the material with EcoGraf’s high purity Epanko battery anode material.

The Evolution of U.S. Medical Tourism Virtual Summit: Insights and Perspectives

Retrieved on: 
Thursday, October 27, 2022
GHR, Association, Relaxation, Public sector, Health, Medicine, History, Korean Government Scholarship Program, Travel, Private sector, Marketing, Solution, Industry, Medical tourism, Technology, EST, Patient, Communication, Education, BEACH, Information Communications Technology education in the Philippines, KTO, Consultant, PALM, Tourism, Pharmaceutical industry, Health insurance, Rocky Mountains

PALM BEACH GARDENS, Fla., Oct. 27, 2022 /PRNewswire/ -- Korea Tourism Organization and Global Healthcare Resources and the Medical Tourism Association have partnered to launch a private medical travel event for the American marketplace.

Key Points: 
  • PALM BEACH GARDENS, Fla., Oct. 27, 2022 /PRNewswire/ -- Korea Tourism Organization and Global Healthcare Resources and the Medical Tourism Association have partnered to launch a private medical travel event for the American marketplace.
  • We have worked with the Korean Government since we partnered with Korea to launch their medical tourism initiative almost 15 years ago.
  • The Medical Tourism Association has three tenets: Transparency, Communication and Education.
  • The Medical Tourism Association works with governments to help launch strategic and long-term initiatives in medical tourism across all stakeholders.

The Evolution of U.S. Medical Tourism Virtual Summit: Insights and Perspectives

Retrieved on: 
Thursday, October 27, 2022
GHR, Association, Relaxation, Public sector, Health, Medicine, History, Korean Government Scholarship Program, Travel, Private sector, Marketing, Solution, Industry, Medical tourism, Technology, EST, Patient, Communication, Education, BEACH, Multimedia, Information Communications Technology education in the Philippines, KTO, Consultant, PALM, Tourism, Pharmaceutical industry, Health insurance, Rocky Mountains

PALM BEACH GARDENS, Fla., Oct. 27, 2022 /PRNewswire/ -- Korea Tourism Organization and Global Healthcare Resources and the Medical Tourism Association have partnered to launch a private medical travel event for the American marketplace.

Key Points: 
  • PALM BEACH GARDENS, Fla., Oct. 27, 2022 /PRNewswire/ -- Korea Tourism Organization and Global Healthcare Resources and the Medical Tourism Association have partnered to launch a private medical travel event for the American marketplace.
  • This exclusive and private B2B event will bring together American insurance companies, employers, insurance agents and consultants, travel agents and others already actively engaged in medical tourism or looking to do so.
  • We have worked with the Korean Government since we partnered with Korea to launch their medical tourism initiative almost 15 years ago.
  • The Medical Tourism Association works with governments to help launch strategic and long-term initiatives in medical tourism across all stakeholders.

Compass UOL's Alexis Rockenbach is Training the Next Batch of Tech Leaders

Retrieved on: 
Monday, October 24, 2022
Brazilian Institute of Public Opinion and Statistics, The Body Shop, Risk, Culture, Korean Government Scholarship Program, Statistics, Woman, IBGE, Federal Rural University of Amazonia, Policy, Computer science, Program, Partnership, Technology, Student, AWS, Knowledge, NEW, University, Brazilian Institute of Geography and Statistics, Industry, Blockchain, CEO, University of Passo Fundo, Amazon, Environment, Silicon, Creativity, Natura & Co, Society, Record, Rainforest, CompTIA, Compass College of Cinematic Arts, Leadership, Management, Video game, Renewable energy, Creative industries, Film, Rockenbach, Compass

NEW YORK, Oct. 24, 2022 /PRNewswire/ -- Alexis Rockenbach, co-founder and CEO of Compass UOL, told Verb.Company he has a plan to avoid the next big crash by training young people to think about the future. He has already hired the first 5,000 and he is now expanding the scholarship program of his company's academy to other countries.

Key Points: 
  • NEW YORK, Oct. 24, 2022 /PRNewswire/ -- Alexis Rockenbach, co-founder and CEO of Compass UOL, told Verb.Company he has a plan to avoid the next big crash by training young people to think about the future.
  • Alexis Rockenbach, of Compass UOL, allocates at least 50 percent of academy openings to women and minorities.
  • When Rockenbach started his digital consultancy, he and his co-founders took five years to draw their first salary to give the business runway.
  • And that's why he set up Compass Academy, to plug the talent gap in the information technology industry.

Seoul Robotics Launches Industry's Most Versatile Infrastructure-Based 3D Perception Software

Retrieved on: 
Tuesday, March 8, 2022
Perception, BMW, Movement, Airport, Deep learning, Software, Computer, City, 3D, Solution, Robotics, Organization, Privacy, KTL, Safety, E-mart, Growth, Lidar, Efficiency, Rain, Original equipment manufacturer, 2D, Technology, Consumer, AI, Product-form solution, Government, Collection, GLOBE, Korean Government Scholarship Program, Satellite navigation device, Surveying, Seoul Robotics

IRVINE, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Seoul Robotics , the 3D computer vision company using AI deep learning to power the future of autonomy, today introduced an infrastructure-based version of its patented 3D perception software.

Key Points: 
  • IRVINE, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Seoul Robotics , the 3D computer vision company using AI deep learning to power the future of autonomy, today introduced an infrastructure-based version of its patented 3D perception software.
  • Indisputably, 3D systems enable organizations to get deeper, more actionable data, said Jerone Floor, Vice President of Products and Solutions at Seoul Robotics.
  • Seoul Robotics is a 3D perception solution company building a platform that uses AI deep learning to power the future of mobility.
  • Seoul Robotics has offices in Seoul, Munich, California, Raleigh and Detroit and is backed by leading global financial institutions.

OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian Cancer

Retrieved on: 
Wednesday, September 1, 2021
SingHealth, Oregovomab, Terminology, Ovarian cancer, Drug combination, Korea University College of Science, PD-1, KOREA, Paclitaxel, Korean Government Scholarship Program, Cancer, Carboplatin, Korea University College of Medicine, Doxorubicin, Survival, HER2/neu, Bevacizumab, MUC1, PSA, Disease, Platinum, Gynecologic Oncology (journal), Death, TSX Venture Exchange, Antibody, Clinical trial, Overalls, Safety, Risk, Cancer immunology, Patient, Immunoglobulin G, Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., Toxicity, Immunization, Hospital, Nivolumab, Pharmaceutical industry

The study will establish the safety and compatibility of the combination of these agents as possible approaches in patient management(ClinicalTrials.gov Identifier: NCT04938583).

Key Points: 
  • The study will establish the safety and compatibility of the combination of these agents as possible approaches in patient management(ClinicalTrials.gov Identifier: NCT04938583).
  • The second study(ORION-02), led by Clinical Assistant Professor Jack Chan, is being conducted at a single centre in Singapore (National Cancer Centre Singapore).
  • OncoQuest has completed a Phase II study using oregovomab in combination with a TLR-3 agonist (Hiltonol) in the recurrent ovarian cancer setting (ClinicalTrials.gov Identifier: NCT03162562).
  • OncoQuest is also in the process of initiating a clinical trial using oregovomab with niraparib in the recurrent ovarian cancer setting.